• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Candida glabrata and FKS mutations: witnessing the emergence of the true multidrug-resistant Candida.

作者信息

Ostrosky-Zeichner Luis

出版信息

Clin Infect Dis. 2013 Jun;56(12):1733-4. doi: 10.1093/cid/cit140. Epub 2013 Mar 13.

DOI:10.1093/cid/cit140
PMID:23487384
Abstract
摘要

相似文献

1
Candida glabrata and FKS mutations: witnessing the emergence of the true multidrug-resistant Candida.光滑念珠菌与FKS突变：见证真正多重耐药念珠菌的出现
Clin Infect Dis. 2013 Jun;56(12):1733-4. doi: 10.1093/cid/cit140. Epub 2013 Mar 13.
2
Acquisition of Resistance to SCY-078 in Candida glabrata Involves FKS Mutations That both Overlap and Are Distinct from Those Conferring Echinocandin Resistance.光滑念珠菌获得对 SCY-078 的耐药性涉及 FKS 突变，这些突变既重叠又不同于那些赋予棘白菌素类耐药性的突变。
Antimicrob Agents Chemother. 2017 Aug 24;61(9). doi: 10.1128/AAC.00833-17. Print 2017 Sep.
3
FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia.FKS 突变的光滑念珠菌：菌血症患者的危险因素和结局。
Clin Infect Dis. 2014 Sep 15;59(6):819-25. doi: 10.1093/cid/ciu407. Epub 2014 May 30.
4
In Vitro Exposure to Increasing Micafungin Concentrations Easily Promotes Echinocandin Resistance in Candida glabrata Isolates.体外暴露于不断增加的米卡芬净浓度很容易促进光滑念珠菌分离株对棘白菌素产生耐药性。
Antimicrob Agents Chemother. 2017 Jan 24;61(2). doi: 10.1128/AAC.01542-16. Print 2017 Feb.
5
Rate of FKS Mutations among Consecutive Candida Isolates Causing Bloodstream Infection.引起血流感染的念珠菌连续分离株中FKS突变率
Antimicrob Agents Chemother. 2015 Dec;59(12):7465-70. doi: 10.1128/AAC.01973-15. Epub 2015 Sep 21.
6
Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong Activity against Candida glabrata and C. krusei Isolates Clinically Resistant to Azole and Echinocandin Antifungal Compounds.真菌CYP51抑制剂VT-1161和VT-1129对临床分离的对唑类和棘白菌素类抗真菌化合物耐药的光滑念珠菌和克柔念珠菌菌株表现出强大活性。
Antimicrob Agents Chemother. 2017 Feb 23;61(3). doi: 10.1128/AAC.01817-16. Print 2017 Mar.
7
Resistance to echinocandin antifungal agents in the United Kingdom in clinical isolates of Candida glabrata: Fifteen years of interpretation and assessment.英国光滑念珠菌临床分离株对棘白菌素类抗真菌药物的耐药性：十五年的解读与评估
Med Mycol. 2020 Feb 1;58(2):219-226. doi: 10.1093/mmy/myz053.
8
Antifungal resistance does not necessarily affect Candida glabrata fitness.抗真菌耐药性不一定会影响光滑念珠菌的适应性。
J Chemother. 2014 Feb;26(1):32-6. doi: 10.1179/1973947813Y.0000000100. Epub 2013 Dec 6.
9
Echinocandin Resistance in Candida.念珠菌中的棘白菌素耐药性
Clin Infect Dis. 2015 Dec 1;61 Suppl 6(Suppl 6):S612-7. doi: 10.1093/cid/civ791.
10
Echinocandin resistance and population structure of invasive Candida glabrata isolates from two university hospitals in Germany and Austria.德国和奥地利两家大学医院侵袭性光滑念珠菌分离株的棘白菌素耐药性及种群结构
Mycoses. 2016 May;59(5):312-8. doi: 10.1111/myc.12472. Epub 2016 Jan 25.

引用本文的文献

1
Next-generation antifungal drugs: Mechanisms, efficacy, and clinical prospects.新一代抗真菌药物：作用机制、疗效及临床前景。
Acta Pharm Sin B. 2025 Aug;15(8):3852-3887. doi: 10.1016/j.apsb.2025.06.013. Epub 2025 Jun 23.
2
The multidrug-resistant complex and phylogenetic related species: Insights into antifungal resistance mechanisms.多重耐药复合体及系统发育相关物种：对抗真菌耐药机制的见解
Curr Res Microb Sci. 2025 Jan 28;8:100354. doi: 10.1016/j.crmicr.2025.100354. eCollection 2025.
3
Echinocandin persistence directly impacts the evolution of resistance and survival of the pathogenic fungus .
棘白菌素类药物的持久性直接影响致病真菌耐药性的演变和生存。
mBio. 2024 Apr 10;15(4):e0007224. doi: 10.1128/mbio.00072-24. Epub 2024 Mar 19.
4
Molecular fingerprinting by multi-locus sequence typing identifies microevolution and nosocomial transmission of in Kuwait.多基因序列分型的分子指纹图谱鉴定了科威特 的微进化和医院感染传播。
Front Public Health. 2023 Sep 8;11:1242622. doi: 10.3389/fpubh.2023.1242622. eCollection 2023.
5
First Report of Azole-Resistant with TR/Y121F/T289A Mutations in Kuwait and an Update on Their Occurrence in the Middle East.科威特首例报告唑类耐药且伴有TR/Y121F/T289A突变情况及中东地区该情况的最新进展
J Fungi (Basel). 2023 Jul 25;9(8):784. doi: 10.3390/jof9080784.
6
Strategies to Prevent Transmission of in Healthcare Settings.医疗机构中预防[病原体名称未给出]传播的策略。
Curr Fungal Infect Rep. 2023;17(1):36-48. doi: 10.1007/s12281-023-00451-7. Epub 2023 Jan 26.
7
Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible?解读重症监护病房侵袭性念珠菌病的流行病学：是否可行？
Infection. 2021 Dec;49(6):1107-1131. doi: 10.1007/s15010-021-01640-7. Epub 2021 Jun 16.
8
: Epidemiology, Diagnosis, Pathogenesis, Antifungal Susceptibility, and Infection Control Measures to Combat the Spread of Infections in Healthcare Facilities.流行病学、诊断、发病机制、抗真菌药敏性以及控制医疗机构感染传播的感染控制措施。
Microorganisms. 2021 Apr 11;9(4):807. doi: 10.3390/microorganisms9040807.
9
Candida kefyr in Kuwait: Prevalence, antifungal drug susceptibility and genotypic heterogeneity.科威特假丝酵母菌：流行情况、抗真菌药物敏感性和基因异质性。
PLoS One. 2020 Oct 27;15(10):e0240426. doi: 10.1371/journal.pone.0240426. eCollection 2020.
10
Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait.科威特临床光滑念珠菌分离株中抗真菌药物敏感性、棘白菌素类耐药的分子基础以及氟康唑耐药的分子流行病学。
Sci Rep. 2020 Apr 10;10(1):6238. doi: 10.1038/s41598-020-63240-z.